106 related articles for article (PubMed ID: 9127456)
1. Endogenous nitric oxide production in Kawasaki disease.
Tsukahara H; Kikuchi K; Matsuda M; Saito M; Hata I; Tsuchida S; Sudo M
Scand J Clin Lab Invest; 1997 Feb; 57(1):43-7. PubMed ID: 9127456
[TBL] [Abstract][Full Text] [Related]
2. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease.
Wang CL; Wu YT; Lee CJ; Liu HC; Huang LT; Yang KD
J Pediatr; 2002 Oct; 141(4):560-5. PubMed ID: 12378198
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and aneurysm formation in Kawasaki disease.
Iizuka T; Oishi K; Sasaki M; Hatanaka Y; Minatogawa Y; Uemura S; Koike M
Acta Paediatr; 1997 May; 86(5):470-3. PubMed ID: 9183484
[TBL] [Abstract][Full Text] [Related]
4. Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures.
Weinberg JB; Lang T; Wilkinson WE; Pisetsky DS; St Clair EW
Arthritis Res Ther; 2006; 8(5):R140. PubMed ID: 16907988
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary nitric oxide oxidation products in children with active coeliac disease.
van Straaten EA; Koster-Kamphuis L; Bovee-Oudenhoven IM; van der Meer R; Forget PP
Acta Paediatr; 1999 May; 88(5):528-31. PubMed ID: 10426175
[TBL] [Abstract][Full Text] [Related]
6. Urinary NOx:creatinine ratios during gluten challenge in children with celiac disease.
Koster-Kamphuis L; van Straaten EA; Kors WA; De Schrijver JE; Bovee-Oudenhoven IM; vandDer Meer R; Forget PP
J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):372-5. PubMed ID: 12604977
[TBL] [Abstract][Full Text] [Related]
7. Increased nitric oxide production by neutrophils in early stage of Kawasaki disease.
Yoshimura K; Tatsumi K; Iharada A; Tsuji S; Tateiwa A; Teraguchi M; Ogino H; Kaneko K
Eur J Pediatr; 2009 Sep; 168(9):1037-41. PubMed ID: 19020897
[TBL] [Abstract][Full Text] [Related]
8. Assessment of endogenous nitric oxide formation in newborns: measurement of urinary nitrite and nitrate concentrations.
Tsukahara H; Takeuchi M; Hata I; Hiraoka M; Kotsuji F; Sudo M; Mayumi M
Biol Neonate; 1997; 72(5):322-6. PubMed ID: 9395843
[TBL] [Abstract][Full Text] [Related]
9. Urinary nitrite excretion after prophylactic intravenous immunoglobulin in premature infants.
Ozkan H; Uzuner N; Oren H; Cabuk N; Işlekel H
Biol Neonate; 2000 Feb; 77(2):101-4. PubMed ID: 10657687
[TBL] [Abstract][Full Text] [Related]
10. The Complexities of the Diagnosis and Management of Kawasaki Disease.
Rowley AH
Infect Dis Clin North Am; 2015 Sep; 29(3):525-37. PubMed ID: 26154665
[TBL] [Abstract][Full Text] [Related]
11. Changes in cardiac troponin I in Kawasaki disease before and after treatment with intravenous gammaglobulin.
Kim M; Kim K
Jpn Circ J; 1998 Jul; 62(7):479-82. PubMed ID: 9707002
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide metabolites, cyclic guanosine 3,5 monophosphate and dimethylarginines during and after uncomplicated pregnancies: a longitudinal study.
Egberts J; van den Bosch N; Brand R
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):35-40. PubMed ID: 10192482
[TBL] [Abstract][Full Text] [Related]
13. Changes in plasma hydrogen sulfide and nitric oxide levels and their clinical significance in children with Kawasaki disease.
Li XH; Zhang CY; Wu JX; Zhang T
Chin Med J (Engl); 2011 Nov; 124(21):3445-9. PubMed ID: 22340156
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
Mortazavi SH; Amin R; Alyasin S; Kashef S; Karimi MH; Babaei M; Younesi V
Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):188-97. PubMed ID: 25780885
[TBL] [Abstract][Full Text] [Related]
15. Elevated Inducible Nitric Oxide Levels and Decreased Hydrogen Sulfide Levels Can Predict the Risk of Coronary Artery Ectasia in Kawasaki Disease.
Song R; Liu G; Li X; Xu W; Liu J; Jin H
Pediatr Cardiol; 2016 Feb; 37(2):322-9. PubMed ID: 26499359
[TBL] [Abstract][Full Text] [Related]
16. Sensorineural hearing loss: an underdiagnosed complication of Kawasaki disease.
Magalhães CM; Magalhães Alves NR; Oliveira KM; Silva IM; Gandolfi L; Pratesi R
J Clin Rheumatol; 2010 Oct; 16(7):322-5. PubMed ID: 20859226
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
18. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Junker W; Alexander K; Frölich JC
Circulation; 1997 Apr; 95(8):2068-74. PubMed ID: 9133517
[TBL] [Abstract][Full Text] [Related]
19. Exercise increases systemic nitric oxide production in men.
Bode-Böger SM; Böger RH; Schröder EP; Frölich JC
J Cardiovasc Risk; 1994 Aug; 1(2):173-8. PubMed ID: 7606631
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.
O'Byrne S; Forte P; Roberts LJ; Morrow JD; Johnston A; Anggård E; Leslie RD; Benjamin N
Diabetes; 2000 May; 49(5):857-62. PubMed ID: 10905497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
